Wellington Management Group’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
Other funds holding PRQR
PFM
OM
PM
MCM
MAM
Wellington Management Group's PRQR Position: Q2 2022 in Review
Wellington Management Group sold out of ProQR Therapeutics (PRQR) in Q2 2022, closing a stake of 3,084,150 shares — an estimated $2.79M sold.
Wellington Management Group first reported a position in PRQR in Q2 2019 and held it in 12 quarters. The position peaked at $54.5M in Q4 2019. 51 funds tracked by Wall St. Rank hold PRQR as of Q2 2022.
- Wellington Management Group reported no remaining ProQR Therapeutics position as of Q2 2022 after selling out during the quarter.
- Wellington Management Group sold 3,084,150 ProQR Therapeutics shares in Q2 2022, an estimated $2.79M.
- Wellington Management Group first reported a position in ProQR Therapeutics in Q2 2019 and held it in 12 quarters.
- Wellington Management Group's ProQR Therapeutics position peaked at $54.5M in Q4 2019.
- 51 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2022.
Based on Wellington Management Group's 13F filing for Q2 2022, filed 15 Aug 2022.